Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 5/2018

29.05.2018 | Case Report

A case of an elderly female with diffuse hepatic hemangiomatosis complicated with multiple organic dysfunction and Kasabach–Merritt syndrome

verfasst von: Yoshiaki Shimizu, Takuya Komura, Takuya Seike, Hitoshi Omura, Tatsuo Kumai, Takashi Kagaya, Hajime Ohta, Atsuhiro Kawashima, Kenichi Harada, Shuichi Kaneko, Masashi Unoura

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Since diffuse hepatic hemangiomatosis (DHH) is an extremely rare disease especially in adults, the etiology and natural course of adult-onset DHH has not been well understood. We report a case of DHH complicated with multiple organic dysfunction and Kasabach–Merritt syndrome (KMS) in an 83-year-old female. She presented with mild abdominal distension and laboratory findings revealed thrombocytopenia and abnormal coagulation, indicating disseminated intravascular coagulation (DIC). Enhanced computed tomography revealed diffuse, hypodense hepatic nodules with delayed enhancement involving the whole liver, and multiple hypodense splenic legions. To obtain a definitive diagnosis, laparoscopic-guided biopsy was performed. Histological findings revealed irregularly dilated non-anastomotic vascular spaces, which were lined with flat endothelial cells without cellular atypia. We diagnosed this as DHH complicated with splenic lesions and KMS. Although the patient was treated with symptomatic treatment, such as anti-coagulation therapy, hemangiomatous lesions, especially in the spleen, progressed rapidly, leading to worsening of DIC. Finally, the patient died of multiple organ failure at 12 months after diagnosis. A postmortem examination demonstrated diffuse hemangiomatosis of not only the liver and spleen, but also the adrenal glands and bone marrow. Despite no malignant histologically, DHH can be fatal if it progresses rapidly within a short period of time.
Literatur
1.
Zurück zum Zitat Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375–423.PubMed Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375–423.PubMed
2.
Zurück zum Zitat Vilgrain V, Boulos L, Vullierme MP, et al. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics. 2000;20:379–97.CrossRefPubMed Vilgrain V, Boulos L, Vullierme MP, et al. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics. 2000;20:379–97.CrossRefPubMed
3.
Zurück zum Zitat Lopriore E, Markhorst DG. Diffuse neonatal haemangiomatosis: new views on diagnostic criteria and prognosis. Acta Paediatr. 1999;88:93–7.CrossRefPubMed Lopriore E, Markhorst DG. Diffuse neonatal haemangiomatosis: new views on diagnostic criteria and prognosis. Acta Paediatr. 1999;88:93–7.CrossRefPubMed
4.
Zurück zum Zitat Jhaveri KS, Vlachou PA, Guindi M, et al. Association of hepatic hemangiomatosis with giant cavernous hemangioma in the adult population: prevalence, imaging appearance, and relevance. AJR Am J Roentgenol. 2011;196:809–15.CrossRefPubMed Jhaveri KS, Vlachou PA, Guindi M, et al. Association of hepatic hemangiomatosis with giant cavernous hemangioma in the adult population: prevalence, imaging appearance, and relevance. AJR Am J Roentgenol. 2011;196:809–15.CrossRefPubMed
5.
Zurück zum Zitat Selmaier M, Cidlinsky K, Ell C, et al. Liver hemangiomatosis in Osler’s disease. Dtsch Med Wochenschr. 1993;118:1015–9.CrossRefPubMed Selmaier M, Cidlinsky K, Ell C, et al. Liver hemangiomatosis in Osler’s disease. Dtsch Med Wochenschr. 1993;118:1015–9.CrossRefPubMed
6.
7.
Zurück zum Zitat Ozakyol A, Kebapci M. Enhanced growth of hepatic hemangiomatosis in two adults after postmenopausal estrogen replacement therapy. Tohoku J Exp Med. 2006;210:257–61.CrossRefPubMed Ozakyol A, Kebapci M. Enhanced growth of hepatic hemangiomatosis in two adults after postmenopausal estrogen replacement therapy. Tohoku J Exp Med. 2006;210:257–61.CrossRefPubMed
8.
Zurück zum Zitat Feurle GE. Arteriovenous shunting and cholestasis in hepatic hemangiomatosis associated with metoclopramide. Gastroenterology. 1990;99:258–62.CrossRefPubMed Feurle GE. Arteriovenous shunting and cholestasis in hepatic hemangiomatosis associated with metoclopramide. Gastroenterology. 1990;99:258–62.CrossRefPubMed
9.
Zurück zum Zitat Yoo BR, Han HY, Choi SY, et al. Giant cavernous hemangioma coexistent with diffuse hepatic hemangiomatosis presenting as portal vein thrombosis and hepatic lobar atrophy. Ultrasonography. 2014;33:65–70.CrossRefPubMed Yoo BR, Han HY, Choi SY, et al. Giant cavernous hemangioma coexistent with diffuse hepatic hemangiomatosis presenting as portal vein thrombosis and hepatic lobar atrophy. Ultrasonography. 2014;33:65–70.CrossRefPubMed
10.
Zurück zum Zitat Batista A, Matos AP, Neta JO, et al. Diffuse hepatic hemangiomatosis in the adult without extra-hepatic involvement: an extremely rare occurrence. J Clin Imaging Sci. 2014;4:43.CrossRefPubMedPubMedCentral Batista A, Matos AP, Neta JO, et al. Diffuse hepatic hemangiomatosis in the adult without extra-hepatic involvement: an extremely rare occurrence. J Clin Imaging Sci. 2014;4:43.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Capilli F, Weinbeck M, Czerny M, et al. A rare case of diffuse hemangiomatosis of the spleen with splenic rupture following aortic valve replacement. Case Rep Radiol. 2017;2017:9164749.PubMedPubMedCentral Capilli F, Weinbeck M, Czerny M, et al. A rare case of diffuse hemangiomatosis of the spleen with splenic rupture following aortic valve replacement. Case Rep Radiol. 2017;2017:9164749.PubMedPubMedCentral
12.
Zurück zum Zitat Militz M, Carlotto JR, Schmitz LD, et al. Diffuse hepatic hemangiomatosis of rapid growth after Bariatric surgery. Dig Liver Dis. 2016;48:1513.CrossRefPubMed Militz M, Carlotto JR, Schmitz LD, et al. Diffuse hepatic hemangiomatosis of rapid growth after Bariatric surgery. Dig Liver Dis. 2016;48:1513.CrossRefPubMed
13.
Zurück zum Zitat Marinis A, Kairi E, Theodosopoulos T, et al. Right colon and liver hemangiomatosis: a case report and a review of the literature. World J Gastroenterol. 2006;12:6405–7.CrossRefPubMedPubMedCentral Marinis A, Kairi E, Theodosopoulos T, et al. Right colon and liver hemangiomatosis: a case report and a review of the literature. World J Gastroenterol. 2006;12:6405–7.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Kim EH, Park SY, Ihn YK, et al. Diffuse hepatic hemangiomatosis without extrahepatic involvement in an adult patient. Korean J Radiol. 2008;9:559–62.CrossRefPubMedPubMedCentral Kim EH, Park SY, Ihn YK, et al. Diffuse hepatic hemangiomatosis without extrahepatic involvement in an adult patient. Korean J Radiol. 2008;9:559–62.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Kim JD, Chang UI, Yang JM. Clinical challenges and images in GI. Diffuse hepatic hemangiomatosis involving the entire liver. Gastroenterology. 2008;134:1830 (2197).CrossRefPubMed Kim JD, Chang UI, Yang JM. Clinical challenges and images in GI. Diffuse hepatic hemangiomatosis involving the entire liver. Gastroenterology. 2008;134:1830 (2197).CrossRefPubMed
16.
Zurück zum Zitat Liu X, Yang Z, Tan H, et al. Giant liver hemangioma with adult Kasabach–Merritt syndrome: case report and literature review. Medicine (Baltimore). 2017;96:e7688.CrossRef Liu X, Yang Z, Tan H, et al. Giant liver hemangioma with adult Kasabach–Merritt syndrome: case report and literature review. Medicine (Baltimore). 2017;96:e7688.CrossRef
17.
Zurück zum Zitat Mahajan D, Miller C, Hirose K, et al. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. J Hepatol. 2008;49:867–70.CrossRefPubMed Mahajan D, Miller C, Hirose K, et al. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. J Hepatol. 2008;49:867–70.CrossRefPubMed
18.
Zurück zum Zitat Mitchell A, Adams LA, MacQuillan G, et al. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl. 2008;14:210–3.CrossRefPubMed Mitchell A, Adams LA, MacQuillan G, et al. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl. 2008;14:210–3.CrossRefPubMed
19.
Zurück zum Zitat Toro A, Mahfouz AE, Ardiri A, et al. What is changing in indications and treatment of hepatic hemangiomas. A review. Ann Hepatol. 2014;13:327–39.PubMed Toro A, Mahfouz AE, Ardiri A, et al. What is changing in indications and treatment of hepatic hemangiomas. A review. Ann Hepatol. 2014;13:327–39.PubMed
20.
Zurück zum Zitat Tsukagoshi H, Iwasaki Y, Toyoda M, et al. An autopsy case of systemic hemangiomatosis with honeycomb-like liver and focal splenic sarcomatoid changes. Intern Med. 1998;37:847–52.CrossRefPubMed Tsukagoshi H, Iwasaki Y, Toyoda M, et al. An autopsy case of systemic hemangiomatosis with honeycomb-like liver and focal splenic sarcomatoid changes. Intern Med. 1998;37:847–52.CrossRefPubMed
Metadaten
Titel
A case of an elderly female with diffuse hepatic hemangiomatosis complicated with multiple organic dysfunction and Kasabach–Merritt syndrome
verfasst von
Yoshiaki Shimizu
Takuya Komura
Takuya Seike
Hitoshi Omura
Tatsuo Kumai
Takashi Kagaya
Hajime Ohta
Atsuhiro Kawashima
Kenichi Harada
Shuichi Kaneko
Masashi Unoura
Publikationsdatum
29.05.2018
Verlag
Springer Japan
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 5/2018
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-018-0871-3

Weitere Artikel der Ausgabe 5/2018

Clinical Journal of Gastroenterology 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.